GlassScriptPhysician profile
Brooke Little
NPI 1710429378
$1,710.02
in general payments reported to CMS, 2019-2025
7 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 88% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.60 · 2023: $316 · 2024: $272 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014 · Travel and Lodging: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.21 |
| Travel and Lodging | $658.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $900.95 | 2025 | Iqirvo |
| Gilead Sciences, INC. | $559.72 | 2022-2025 | Livdelzi, Epclusa |
| Enterra Medical, INC. | $152.98 | 2023 | |
| Madrigal Pharmaceuticals | $36.46 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $26.84 | 2023 | Ocaliva |
| Intra-Sana Laboratories | $20.00 | 2022 | |
| Exact Sciences Corporation | $13.07 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.